Additional New Jersey Case Announced As Part Of Federal Health Care Fraud Takedown In Northeastern U.S.
Outcome
OIG enforcement action against Additional New Jersey Case Announced As Part Of Federal Health Care Fraud Takedown In Northeastern U.S. for controlled substance. Penalty: $800 million.
Details
Additional New Jersey Case Announced As Part Of Federal Health Care Fraud Takedown In Northeastern U.S. — OIG Enforcement (2026)
OIG took enforcement action against Additional New Jersey Case Announced As Part Of Federal Health Care Fraud Takedown In Northeastern U.S. in NJ in 2026 involving controlled substance violations in the Physician Practices sector.
Penalty: $800 million
Violation types: Controlled Substance
Entity type: Physician Practice
Penalty type: Criminal
Location: NJ
Source: Additional New Jersey Case Announced As Part Of Federal Health Care Fraud Takedown In Northeastern U.S.
How Crucible Prevents This
Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works